3/2/2021WuXi AppTec Completes Acquisition of Gene Therapy CRDO OXGENE

3/2/2021ADC Developer Suzhou Medilink Therapeutics Secures $50M in A1 Financin...

3/1/2021Eisai Secures Anti-Insomnia Drug Dayvigo in Hong Kong

3/1/2021Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie

3/1/2021Bayer Signs Strategic Alliance MOU with China Alliance for Rare Diseas...

3/1/2021Junshi Bio and AstraZeneca Announce Strategic Collaboration to Commerc...

2/26/2021CANbridge Pharma and Puma Biotech Agree to Terminate NERLYNX License...

2/26/2021Financial-related Company News in Brief

2/26/2021241 A Share-Listed Chinese MedPharm Cos Release 2020 Performance Guida...

2/25/2021Puma Biotech and Pierre Fabre Amend NERLYNX License Deal to Include G...

2/24/2021Kuehne+Nagel Forms Strategic Partnership with Chinese Pharma Specialis...

2/24/2021Snapshot of MNC Products in the 2020 NRDL

2/23/2021Graviton Enters into Global Licensing Agreement for ROCK2 Inhibitor fr...

2/23/2021Solentim Expands Gglobal Rreach, Opening New Operation in China (Free)

2/22/2021AstraZeneca and HKSTP Launch Co-incubation Program for Oncology-relate...

2/22/2021Junshi Bio Wins Chinese Conditional Approval for 2nd Indication for T...

2/18/20212020 Performance of Leading MNC Pharma Companies in China

2/17/2021BITT and BeiGene Enter Exclusive Option and License Deal to Develop No...

2/17/2021Scynexis and Hansoh Announce Licensing / Partnership Deal for Ibrexafu...

2/17/2021Provention Bio and Huadong Announce Strategic Collaboration for PRV-32...

2/17/2021Luye and Towa Enter Strategic Deal for Rivastigmine Multi-Day Transder... (Free)

2/17/2021Cend Therapeutics and Qilu Pharmaceutical Announce Partnership

2/14/2021Adagene Completes $140M NASDAQ IPO

2/12/2021AstraZeneca Reports 2020 Performance, Highlighting China Challenges

2/9/2021Drug Farm Closes $56M Financing to Advance Lead Hepatitis B Drug into ... (Free)

2/9/2021Chance Pharma In-Licenses Drug-Device Combo AER-901 from Aerami Ther...

2/9/2021Antibe Therapeutics and Nuance Pharma Announce Strategic Licensing Dea...

2/9/2021Betta Pharma Mulls US$800M Hong Kong IPO in the First Half

2/9/2021Hengrui Medicine and Yingli Pharma Reach a Strategic Deal for Oncology...

2/9/2021Apollomics, Inc. and Edison Oncology Announce Licensing Agreement for ...

Page:1/19 Total number of articles:543: [First][<<] [1] [2] [3] [4] [5] [>>] [End]